MARY MANOUSOS

826 total citations
9 papers, 472 citations indexed

About

MARY MANOUSOS is a scholar working on Infectious Diseases, Genetics and Organic Chemistry. According to data from OpenAlex, MARY MANOUSOS has authored 9 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Genetics and 2 papers in Organic Chemistry. Recurrent topics in MARY MANOUSOS's work include Virus-based gene therapy research (2 papers), Bacteriophages and microbial interactions (2 papers) and Antibiotic Resistance in Bacteria (2 papers). MARY MANOUSOS is often cited by papers focused on Virus-based gene therapy research (2 papers), Bacteriophages and microbial interactions (2 papers) and Antibiotic Resistance in Bacteria (2 papers). MARY MANOUSOS collaborates with scholars based in United States and China. MARY MANOUSOS's co-authors include MARGARET R. ANDERSON, James A. Retsema, G. Michael Bright, Agnès Girard, S. A. Mayyasi, J. A. Faiella, John A. Williams, J.W. Petitpas, Joanna Clancy and Paul R. McGuirk and has published in prestigious journals such as Applied and Environmental Microbiology, JNCI Journal of the National Cancer Institute and Antimicrobial Agents and Chemotherapy.

In The Last Decade

MARY MANOUSOS

9 papers receiving 426 citations

Peers

Countries citing papers authored by MARY MANOUSOS

Since Specialization

Citations

This map shows the geographic impact of MARY MANOUSOS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MARY MANOUSOS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MARY MANOUSOS more than expected).

Fields of papers citing papers by MARY MANOUSOS

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MARY MANOUSOS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MARY MANOUSOS. The network helps show where MARY MANOUSOS may publish in the future.

Co-authorship network of co-authors of MARY MANOUSOS

This figure shows the co-authorship network connecting the top 25 collaborators of MARY MANOUSOS. A scholar is included among the top collaborators of MARY MANOUSOS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MARY MANOUSOS. MARY MANOUSOS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Assays to Detect and Characterize Synthetic Agents that Inhibit the ErmC Methyltransferase. 1995 ·The Journal of Antibiotics ·Joanna Clancy, (unknown), J.W. Petitpas, MARY MANOUSOS, John A. Williams, J. A. Faiella, (unknown), Paul R. McGuirk	28
2	Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes 1994 ·Antimicrobial Agents and Chemotherapy ·(unknown), Amelia Tait‐Kamradt, J.W. Petitpas, MARY MANOUSOS, Paul R. McGuirk, Timothy A. Subashi, (unknown), L Wondrack	7
3	(6R,8S)-(2-benzimidazolyl)hydroxymethylpenicillanic acids as potent antibacterial agents and .BETA.-lactamase inhibitors. 1991 ·The Journal of Antibiotics ·Yuhpyng L. Chen, (unknown), (unknown), James A. Retsema, MARGARET R. ANDERSON, MARY MANOUSOS, J. Barrett	6
4	Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms 1987 ·Antimicrobial Agents and Chemotherapy ·James A. Retsema, Agnès Girard, (unknown), MARY MANOUSOS, MARGARET R. ANDERSON, G. Michael Bright, (unknown), (unknown), (unknown)	375
5	Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones. A new class of .BETA.-lactamase inhibitors. 1987 ·The Journal of Antibiotics ·Yuhpyng L. Chen, (unknown), (unknown), (unknown), Willard M. Welch, Laura L. Kiessling, James A. Retsema, S L Haskell, MARGARET R. ANDERSON, MARY MANOUSOS, John F. Barrett	29
6	New method for large-scale growth; and concentration of the Epstein-Barr viruses 1980 ·Applied and Environmental Microbiology ·(unknown), MARY MANOUSOS, Karin Münch, (unknown), Leigh H. Fisher, S. A. Mayyasi, (unknown), Robert Stevens, Keith E. Jensen	7
7	Feasibility studies of oncornavirus production in microcarrier cultures 1980 ·In Vitro Cellular & Developmental Biology - Plant ·MARY MANOUSOS, Muhammad Umer Ahmed, (unknown), (unknown), (unknown), R. Stephens, S. A. Mayyasi	10
8	Expression of Mason-Pfizer and Simian Type C Viruses in the Presence of 5-lododeoxyuridine and Dexamethasone2 1977 ·JNCI Journal of the National Cancer Institute ·Muhammad Umer Ahmed, G. Schidlovsky, (unknown), MARY MANOUSOS, S. A. Mayyasi	7
9	Detection of Simian Type-C Particles in Mason-Pfizer Virus Infected Cultures 1976 ·Journal of General Virology ·(unknown), G. Schidlovsky, David Larson, MARY MANOUSOS, S. A. Mayyasi	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact